2016 IALS Seed Grant Award Winners
Seven inaugural IALS Seed Grants have been awarded to the following projects which align with the objectives of the seed grant program and the mission of IALS, which is to accelerate translational projects that improve human health and well-being. Each researcher has been awarded a $50,000 grant to be completed within a period of 12 months.
- Katherine Boyer - “Misfit Shine Detection of Change in Physical Activity: Evidence and Translation for a new Clinical Outcome Tool”
- Michelle Farkas - “Harnessing Macrophages as Cell-Based Delivery Agents for Cancer Imaging and Treatment”
- Jeanne Hardy - “Furoxan-based Caspase-6 Inhibitors for Treatment of Neurodegeneration”
- Karen Kalmakis - “Real-time continuous cortisol monitoring: An innovation for stress self-management”
- Vince Rotello - “shRNA Therapeutics for Non-Hodgkin's Lymphoma”
- Yubing Sun - “Self-powered integrated blood separation and SERS-based immunoassay (SIBSI) device for point of care analysis of pancreatic cancer biomarkers”
- Jim Watkins - “Autonomous Sensor Platforms for In-Home and On-Body Health Monitoring”
The seed grant program is designed to enable both ongoing individual projects and new collaborative projects with other UMass researchers, such as those in the UMass medical school, other UMass campuses, as well as industry researchers. These projects leverage current technologies or discoveries in IALS investigator labs to create evidence needed to advance the project towards pre-IND or clinical development stages. The grants provide funds for use of CROs (contract research organizations) as well as IALS or other facilities, reagents and supplies, and incremental personnel costs.
